Zobrazeno 1 - 10
of 206
pro vyhledávání: '"Han-Sung Kang"'
Autor:
Ran Song, Dong-Eun Lee, Eun-Gyeong Lee, Seeyoun Lee, Han-Sung Kang, Jai Hong Han, Keun Seok Lee, Sung Hoon Sim, Heejung Chae, Youngmee Kwon, Jaeyeon Woo, So-Youn Jung
Publikováno v:
Cancers, Vol 15, Iss 18, p 4451 (2023)
Oncotype DX (ODX), a 21-gene assay, predicts the recurrence risk in early breast cancer; however, it has high costs and long testing times. We aimed to identify clinicopathological factors that can predict the ODX risk group and serve as alternatives
Externí odkaz:
https://doaj.org/article/86368cc8be544dd2b3618d6865b1d201
Autor:
Yunju Kim, Sung Hoon Sim, Boram Park, In Hye Chae, Jai Hong Han, So-Youn Jung, Seeyoun Lee, Youngmi Kwon, In Hae Park, Kyounglan Ko, Chan Wha Lee, Keun Seok Lee, Han-Sung Kang, Eun Sook Lee
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract We investigated magnetic resonance imaging (MRI) criteria identifying residual tumours in patients with triple-negative and human epidermal growth factor receptor type 2-positive (HER2+) breast cancer following neoadjuvant chemotherapy. Retr
Externí odkaz:
https://doaj.org/article/e9e8380a776043ca99b512895ec1127e
Autor:
Heein Jo, Eun-Gyeong Lee, Eunjin Song, Jai Hong Han, So-Youn Jung, Han-Sung Kang, Eun Sook Lee, Seeyoun Lee
Publikováno v:
Korean Journal of Clinical Oncology, Vol 16, Iss 1, Pp 18-24 (2020)
Purpose The ACOSOG Z0011 trial has proven the oncological safety of sentinel lymph node biopsy (SLBx) for node negative breast cancer. Accordingly, treatment paradigm including axilla surgery was changed. We retrospectively reviewed breast cancer pat
Externí odkaz:
https://doaj.org/article/bbc41405d6374a63af49b26ce5e058b0
Autor:
Hyeon Woo Kim, Jae Eun Park, Minjae Baek, Heejoo Kim, Hwee Won Ji, Sung Hwan Yun, Dawoon Jeong, Juyeon Ham, Sungbin Park, Xinpei Lu, Han-Sung Kang, Sun Jung Kim
Publikováno v:
Cancers, Vol 14, Iss 5, p 1232 (2022)
Background: Tamoxifen (tam) is widely used to treat estrogen-positive breast cancer. However, cancer recurrence after chemotherapy remains a major obstacle to achieve good patient prognoses. In this study, we aimed to identify genes responsible for e
Externí odkaz:
https://doaj.org/article/3e227be293d3493b8086df85de6ee41c
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Abstract To identify dysregulated genes by abnormal methylation and expression in breast cancer, we genome-wide analyzed methylation and expression microarray data from the Gene Expression Omnibus and the Cancer Genome Atlas database. One of the gene
Externí odkaz:
https://doaj.org/article/8ed5876dd041479f85c6752b2981496d
Autor:
Sung Hoon Sim, Chang-Dae Bae, Youngmi Kwon, Hai-Li Hwang, Shiv Poojan, Hye-In Hong, Kyungtae Kim, Seo-Hee Kang, Han-Seong Kim, Tae-Hyun Um, In Hae Park, Keun Seok Lee, So-Youn Jung, Seeyoun Lee, Han-Sung Kang, Eun Sook Lee, Mi-Kyung Kim, Kyeong-Man Hong, Jungsil Ro
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0182107 (2017)
Recently, we reported cytoskeleton-associated protein2 (CKAP2) as a possible new prognostic breast cancer marker. However, it has not yet been applied in clinic. Therefore, clinical significance of CKAP2 was evaluated in comparison with that of Ki-67
Externí odkaz:
https://doaj.org/article/4e6c5718b3ea4af38b8abbd539e35163
Autor:
Moo Hyun Lee, So-Youn Jung, Sun Hee Kang, Eun Jin Song, In Hae Park, Sun-Young Kong, Young Mee Kwon, Keun Seok Lee, Han-Sung Kang, Eun Sook Lee
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0163370 (2016)
This study evaluated the association of serum HER2 (sHER2) levels at diagnosis with clinicopathologic parameters and disease free survival (DFS) in operable breast cancer patients according to intrinsic subtype.The sHER2 levels were measured using a
Externí odkaz:
https://doaj.org/article/18cc048922bd42d5af5bdb883fcd2493
Autor:
Eunjin Jwa, Kyung Hwan Shin, Hyeon Woo Lim, So-Youn Jung, Seeyoun Lee, Han-Sung Kang, EunSook Lee, Young Hee Park
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0145463 (2015)
INTRODUCTION:The locoregional recurrence (LRR) rate was reported as high as approximately 20% in stage I-II breast cancer following mastectomy. To investigate the risk factors for LRR in pT1-2N0-1 breast cancer patients treated with mastectomy but no
Externí odkaz:
https://doaj.org/article/0e087f2af1df4afdaf9b3948985e644e
Autor:
Han-Sung Kang, Sei Hyun Ahn, Siddhartha Kumar Mishra, Kyeong-Man Hong, Eun Sook Lee, Kyung Hwan Shin, Jungsil Ro, Keun Seok Lee, Mi Kyung Kim
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e84532 (2014)
The insulin-like growth factor (IGF) signaling pathway plays an important role in cancer biology. The IGF 1 receptor (IGF1R) overexpression has been associated with a number of hematological neoplasias and solid tumors including breast cancer. Howeve
Externí odkaz:
https://doaj.org/article/d2311cbce4f64bc99b2b8e8dd1281cae
Autor:
Eun-Gyeong, Lee, Dong-Eun, Lee, Hyun Hee, Kim, Jai Hong, Han, Seeyoun, Lee, Han-Sung, Kang, Eun Sook, Lee, Heejung, Chae, Sung Hoon, Sim, Keun Seok, Lee, Youngmee, Kwon, So-Youn, Jung
Publikováno v:
Cancer Research and Treatment. 55:542-550
Purpose This study investigated pathological complete response (pCR) according to androgen receptor (AR) in breast cancer patients undergoing neoadjuvant chemotherapy and estimated the relationship between AR expression and clinicopathological factor